IL129236A - Monoclonal antibodies against a human act and serine protease complex - Google Patents

Monoclonal antibodies against a human act and serine protease complex

Info

Publication number
IL129236A
IL129236A IL12923697A IL12923697A IL129236A IL 129236 A IL129236 A IL 129236A IL 12923697 A IL12923697 A IL 12923697A IL 12923697 A IL12923697 A IL 12923697A IL 129236 A IL129236 A IL 129236A
Authority
IL
Israel
Prior art keywords
act
psa
monoclonal antibodies
antibody
human
Prior art date
Application number
IL12923697A
Other languages
English (en)
Other versions
IL129236A0 (en
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7808241&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL129236(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of IL129236A0 publication Critical patent/IL129236A0/xx
Publication of IL129236A publication Critical patent/IL129236A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL12923697A 1996-10-09 1997-10-09 Monoclonal antibodies against a human act and serine protease complex IL129236A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19641560A DE19641560A1 (de) 1996-10-09 1996-10-09 Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease
PCT/EP1997/005556 WO1998015580A1 (de) 1996-10-09 1997-10-09 Monoklonale antikörper gegen einen komplex aus humanem act und einer serinprotease

Publications (2)

Publication Number Publication Date
IL129236A0 IL129236A0 (en) 2000-02-17
IL129236A true IL129236A (en) 2002-08-14

Family

ID=7808241

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12923697A IL129236A (en) 1996-10-09 1997-10-09 Monoclonal antibodies against a human act and serine protease complex

Country Status (10)

Country Link
US (2) US6630350B1 (es)
EP (1) EP0929579B1 (es)
JP (1) JP3589303B2 (es)
AT (1) ATE230761T1 (es)
AU (1) AU725332B2 (es)
CA (1) CA2267660A1 (es)
DE (2) DE19641560A1 (es)
ES (1) ES2191173T3 (es)
IL (1) IL129236A (es)
WO (1) WO1998015580A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4855577B2 (ja) * 1998-06-01 2012-01-18 アジェンシス，インコーポレイテッド ヒト癌で発現される新規蛇行性膜貫通抗原およびその使用
CA2311512A1 (en) * 1999-07-24 2001-01-24 Bayer Corporation Reflex method for the detection of prostate cancer
DE10211818B4 (de) * 2002-03-16 2006-07-06 peS Gesellschaft für medizinische Diagnose-Systeme mbH Verfahren zur quantitativen Bestimmung mehrerer Analyten
US20080125582A1 (en) * 2006-10-13 2008-05-29 Bio-Rad Laboratories, Inc. Methods and compositions for stabilizing prostate specific antigen
KR101847004B1 (ko) 2013-07-12 2018-04-10 메르크 파텐트 게엠베하 표적 단백질을 함유하는 샘플로부터 단편들의 활성탄을 이용한 제거
CN104459109B (zh) * 2014-11-25 2016-03-23 成都威尔诺生物科技有限公司 一种用于酶联免疫反应的单组份tmb显色液
CN106198989B (zh) * 2016-06-29 2018-02-16 丹娜（天津）生物科技有限公司 检测前列腺特异抗原与α1‑抗糜蛋白酶复合物的试剂盒
JP7355140B2 (ja) 2022-02-28 2023-10-03 住友ベークライト株式会社 セリンプロテアーゼの検出用または測定用試薬

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002480D0 (sv) 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
EP0511050B1 (fr) 1991-04-17 1996-12-18 Pierre Julien Dispositif comprenant au moins un élément de forme aérodynamique à géométrie modifiable, intégrant un système de contrÔle de la couche limite
DE4322342A1 (de) 1993-07-05 1995-02-09 Gif Ges Fuer Immunologische Fo Verfahren für die Differentialdiagnostik des Prostata-Karzinoms
EP0635575A1 (en) 1993-07-22 1995-01-25 Wallac Oy Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
IL121659A (en) * 1996-10-25 2000-07-16 Bayer Ag Method for determining CPSA in a blood sample
US5856182A (en) 1996-11-18 1999-01-05 Beckman Coulter, Inc. Monoclonal antibodies specific for the PSA-ACT complex

Also Published As

Publication number Publication date
US20030073141A1 (en) 2003-04-17
EP0929579B1 (de) 2003-01-08
DE59709109D1 (de) 2003-02-13
CA2267660A1 (en) 1998-04-16
JP3589303B2 (ja) 2004-11-17
AU725332B2 (en) 2000-10-12
AU4865997A (en) 1998-05-05
WO1998015580A1 (de) 1998-04-16
IL129236A0 (en) 2000-02-17
JP2001502669A (ja) 2001-02-27
DE19641560A1 (de) 1998-04-16
EP0929579A1 (de) 1999-07-21
US6630350B1 (en) 2003-10-07
ES2191173T3 (es) 2003-09-01
ATE230761T1 (de) 2003-01-15

Similar Documents

Publication Publication Date Title
US8114604B2 (en) Tumour markers
EP0540573B2 (en) Assay of free and complexed prostate-specific antigen (psa)
AU2004220156B2 (en) Monoclonal antibody and hybridoma producing the same
WO2017061546A1 (ja) Ｐｉｖｋａ－ｉｉの測定方法、及びｐｉｖｋａ－ｉｉ免疫測定試薬又はキットの製造方法
AU725332B2 (en) Monoclonal antibodies against a human ACT and serine protease complex
EP2884277B1 (en) Method and immunoassay reagent for measuring PIVKA-II
US5973123A (en) Immunoassay for the detection of MIA
CN111303289B (zh) 抗人Tn型糖基化MUC1抗体及其用途
JP2006516114A (ja) Ｓｃｃａアイソフォームの特異的測定のためのイムノアッセー
CN108291915A (zh) Ed-b蛋白在诊断组织增生中的应用
JP6793514B2 (ja) 新規甲状腺癌関連抗原に結合する抗体および甲状腺癌診断剤
US7157286B2 (en) Method for immunologically measuring RCAS1 and kit for measuring the same
JP2007212438A (ja) 癌診断剤および癌診断用キット
JP2558956B2 (ja) ヒト・オステオカルシンの免疫学的測定方法、そのための試薬及びキツト、ヒト・オステオカルシンに対する抗体、それを産生するハイブリドーマ及びそれを産生する方法
KR100378746B1 (ko) 체액내 활성 세포증식억제인자-베타1의 정량 방법 및 이를이용한 암 검사 방법
KR101158986B1 (ko) 인간 ｄｃｃ1에 특이적인 단일클론항체 및 이의 용도
WO2003020115A2 (en) Methods and compositions for the detection of cancer
JPWO2003052102A1 (ja) ブラディオン検出用特異的抗体

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees